FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I or a pharmaceutically acceptable salt or stereoisomer thereof, which have the properties of a Janus kinase inhibitor (JAK). In formula I A is selected from phenyl and heteroaryl; X is independently selected from CH2 and O, wherein at least one X is other than CH2; n is equal to 0; m is equal to 0, 1, 2, 3 or 4; p is equal to 2, 3, 4 or 5; R1 is selected from halogen, oxo (=O), C0-10alkyliminoC0-10alkyl, C1-10alkyl(oxy)0-1(carbonyl)0-1C0-10alkyl, heteroarylC0-10alkyl(oxy)0-1(carbonyl)0-1C0-10alkyl, (C3-12)heterocycloalkylC0-10alkyl(oxy)0-1(carbonyl)0-1C0-10alkyl, C0-10alkyl(oxy)0-1(carbonyl)0-1aminoC0-10alkyl, C3-12cycloalkylC0-10alkyl(oxy)0-1(carbonyl)0-1aminoC0-10alkyl, C0-10alkylamino(oxy)0-1(carbonyl)0-1C0-10alkyl, C3-12cycloalkylamino(hydroxy)0-1(carbonyl)0-1C0-10alkyl, C0-10alkylsulfonylC0-10alkyl, (C3-12)heterocycloalkylC0-10alkylsulfonylC0-10alkyl, (C0-10alkyl)1-2amino, -SO2NH2, -SO2NH(C1-10alkyl), -SO2N(C1-10alkyl)2, C1-10alkylsulfinylC0-10alkyl, thioC1-10alkyl, hydroxy, -(C1-10alkyl)OH, -C0-10alkylalkoxy, cyano, (C1-6alkyl)cyano and C1-6haloalkyl. Invention also relates to a pharmaceutical composition containing the above compounds. .
EFFECT: proposed N-(2-cyano heterocyclyl)pyrazolo pyridones as the Janus kinase inhibitors.
7 cl, 10 tbl, 113 ex
Title | Year | Author | Number |
---|---|---|---|
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2013 |
|
RU2661896C2 |
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2013 |
|
RU2658006C2 |
PYRAZOLE QUINOLINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION | 2012 |
|
RU2621037C2 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
TYROSINE KINASE INHIBITORS | 2006 |
|
RU2408584C2 |
ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
MTOR KINASE INHIBITORS FOR ONCOLOGIC INDICATIONS AND DISEASES ASSOCIATED WITH MTOR/PI3K/AKT BY METABOLISM | 2009 |
|
RU2692796C2 |
Authors
Dates
2018-10-17—Published
2014-03-19—Filed